Solventum Beats Earnings, But Margins & Cash Flow Concerns Linger

Solventums Q1 2026 earnings beat Wall Street estimates, with $2.01 billion in revenue and $1.48 in adjusted EPS. However, adjusted EBITDA missed expectations by 37%, operating margins shrank, and free cash flow burned through $273 million. Despite organic revenue growth of 2.1%, Solventums margins have eroded due to rising expenses, and revenue has been flat for two years. Management maintained full-year EPS guidance, but analysts expect flat revenue. The stock held steady at $69.50, with a market cap of $11.69 billion. CEO Bryan Hanson highlighted strong execution and commercial momentum, but investors should monitor margins and cash trends for long-term prospects. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/eab98001a741de52